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 Chronic periodontitis is an infectious disease resulting in inflammation in the 
supporting tissues of the teeth, progressive attachment and bone loss with pocket 
formation and/or gingival recession or both. This is the most frequently occurring 
form of periodontitis which is commonly seen in adults, but can occur at any age. The 
disease is usually associated with the presence of plaque and calculus. The 
progression of attachment loss usually occurs slowly in this condition but there are 
periods of rapid destruction and progression of the periodontal disease.(1) 
 Periodontitis is usually caused by interactions between many factors like 
bacteria and their by products, immune cells and inflammatory mediators. The plaque 
and calculus present in the teeth are capable of releasing certain substances like 
lipopolysaccharides, antigens and other virulence factors which can travel into the 
gingival tissue and start an inflammatory and immune response which leads to the 
activation of host defense cells. The activation of host immune inflammatory process 
initiate the release of inflammatory mediators such as cytokines, chemokines, 
adipokines, arachidonic acid metabolites are released, which plays important role in 
disease progression and tissue destruction.(2) 
 Adipokines are group of biologically active molecules produced by the 
adipose tissue.  Adipokines such as adiponectin and resistin play an important role in 
periodontal inflammation. These adipokines and cytokines have been shown to play a 
vital role in the host response to infection and periodontal inflammation.(3) 
 Adiponectin is a 30 kDa polypeptide which is specifically and highly 
expressed in human adipose tissues.(4) The adiponectin gene (Adipoq) is located on 
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chromosome 3 at 3q2. It is different from other adipokines as adiponectin exerts anti-
inflammatory and anti-arthrogenic activities.(5) 
 Plasma adiponectin levels are reduced in periodontitis,but after periodontal 
therapy it increases. Adiponectin exhibits its anti-inflammatory property by 
stimulating IL-10 and heme oxygenase 1 which are known to be anti-inflammatory 
and can inhibit the LPS stimulated NF-κB nuclear translocation. It also inhibits the 
production of proinflammatory and proteolytic molecules in periodontal cells.(6) 
 Resistin is a 12.5 kDa adipokine that is a member of a cysteine rich secretory 
protein family.(7) The term “resistin” was proposed for its role in insulin resistance. 
The gene that encodes this molecule called Retn is located on chromosome 19 at 
p13.3. Resistin increases the level of proinflammatory cytokines (IL-1, IL-6, TNF-α, 
IL-12, MCP-1) in human peripheral blood mononuclear cells, macrophages and 
hepatic stellate cells via the nuclear factor-κB  pathway. This shows that resistin may 
have a major role in inflammation.(5,7) 
 Elimination of all inflammation remains a critical objective of periodontal 
therapy. Mechanical instrumentation of roots using curettes is an effective treatment 
for patients with mild to moderate periodontitis. A number of treatment options are 
available for the treatment of periodontal disease ranging from the traditional non 
surgical periodontal therapy to recent surgical treatment modalities utilizing grafts, 
membranes, growth factors and various other tissue engineered products and 
techniques.(8) 
 The primary objective of nonsurgical periodontal therapy is to achieve 
gingival health by completely removing elements that are responsible for the gingival 
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inflammation (i.e., plaque, calculus, and endotoxins) in the oral environment. Both 
hand instruments and ultrasonic instruments are capable of dramatically reducing the 
numbers of subgingival microorganisms.(9) Despite various treatment options non 
surgical periodontal therapy still remains the gold standard of the periodontal 
treatment regimens.(8) 
 GCF is a source of sampling to investigate the condition of periodontal tissues. 
GCF ingredients are composed of many components that have been described as 
markers for periodontal disease development. These comprise host derived enzymes, 
host response modifiers and tissue breakdown products.(10) 
 The literature is with limited information with respect to the association of 
clinical parameters with adiponectin and resistin levels in GCF. The evaluation of 
adiponectin and resistin in GCF of chronic periodontitis patients could be used as a 
biomarker for prediction of active stage of the disease and periodontal destruction. 
However the association between adiponectin and resistin levels in GCF and clinical 
parameters has not been studied in detailed yet. 
 Hence this clinico-biochemical study was designed to evaluate the levels of 
adiponectin and resistin in GCF of subjects with clinically healthy periodontium, 
chronic periodontitis subjects before and after SRP. 
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The aim of the present study was 
1. To evaluate the levels of  adiponectin in GCF of periodontally healthy and 
diseased individuals. 
2. To evaluate the levels of  resistin  in GCF of periodontally healthy and 
diseased individuals. 
3. To find out the association of adiponectin levels in GCF with its clinical 
parameters before and after SRP in periodontitis.  
4. To find out the association of resistin levels in GCF with its clinical 
parameters before and after SRP in periodontitis.  
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 Listgarten MA et al., (1986)(11) reported periodontitis as an inflammatory 
disease of the periodontium which was characterized by a progressive destruction of 
the tissues supporting the tooth. It was caused due to microbial infections from more 
than 300 species of bacteria seen in the oral cavity. Periodontitis progress as periodic, 
relatively short episodes of rapid tissue destruction followed by some repair, and 
prolonged intervening periods of disease remission.  
 Page RC et al., (1991)(12) studied about the role of inflammatory mediators in 
the pathogenesis of periodontal disease. Periodontal diseases were multifactorial 
conditions that are affected by both genetic and environmental risk factors. Risk 
factors for periodontitis include smoking, genetic predisposition, age, gender, stress, 
diet as well as medical conditions. Clinical parameters such as probing depth, 
attachment loss, bleeding on probing, plaque index, radiographic assessment of 
alveolar bone loss provide information about severity of periodontitis but they do not 
measure disease activity. 
Non surgical periodontal therapy 
 Greenstein G et al., (1992)(13) et al reported that scaling is defined as the 
removal of plaque, calculus, and stain from the crown and root surfaces. Root planing 
denotes the removal of cementum or surface dentin that is rough or impregnated with 
calculus, toxins, or microorganisms. During root instrumentation both the procedures 
are employed. Scaling and root planing decreased gram-negative organisms and 
increased gram-positive rods and coccal species. This microbial shift was associated 
with periodontal health. Scaling and root planing reduces inflammation and can 
reduce the severity of chronic periodontitis. 
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 Greenstein G et al., (2000)(14) reviewed that mechanical instrumentation of 
roots with curettes was an efficient treatment for patients with mild to moderate 
periodontitis. Root planing can decrease probing depth, clinical attachment level gain 
and reduce the progression of disease. Increase of clinical attachment level shows the 
development of new connective-tissue attachment.  
  Bhansali R et al., (2014)(15) reviewed that treatment of periodontitis was 
mainly directed towards elimination of pathogens in the subgingival biofilm. To 
achieve this non surgical periodontal therapy can be employed. Non surgical 
periodontal therapy has been proved to improve probing pocket depth and clinical 
attachment level in mild to moderate periodontitis. It can also change host response in 
the periodontal tissues. Mechanical therapy has both supragingival and subgingival 
scaling and debridement of the roots to remove plaque, calculus, endotoxins and other 
plaque retentive factors. 
 Goncalves TE et al., (2014)(16) conducted a study in which he observed 24 
obese and 24 non obese patients with chronic periodontitis. The two group of patients 
underwent SRP. Clinical parameters like probing depth, clinical attachment level, 
bleeding on probing were seen before treatment and they were improved on 3 and 6 
months after treatment. 
 Ozcan E et al., (2016)(17) conducted a study on 32 subjects. At 3 months after 
SRP he found that the visfatin, chemerin and MMP-8 were higher in periodontitis 
patients than that of controls. Visfatin, chemerin and MMP-8 in saliva can be used as 
potential markers for assessing the progress of the treatment of periodontal disease. 
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Adipokines 
 Tilg H et al., (2006)(18) reviewed about the biology of adipokines and 
postulated that adipose tissue not only serves as an energy store but it was an 
important factor in the regulation of various pathological processes. Adipose tissue 
releases many products. The soluble factors released from adipose tissue are called 
adipocytokines. Adiponectin, leptin, resistin and visfatin are adipocytokines. They 
show an association between obesity, insulin resistance and related inflammatory 
disorders.  
 Karthikeyan BV et al., (2007)(19) categorized 45 subjects into healthy, 
chronic gingivitis and chronic periodontitis and conducted a study on leptin which 
was an adipokine. GCF leptin concentration in healthy was higher than that of chronic 
gingivitis and chronic periodontitis patients. 
 Rabe K et al., (2008)(20) reviewed that adipose tissue was an active endocrine 
organ which regulates fat mass, nutrient homeostasis  and secretes a large number of 
bioactive mediators called adipokines which modulates hemostasis, blood pressure, 
lipid and glucose metabolism, inflammation, and atherosclerosis. 
 Yilmaz G et al., (2014)(21) reported about ghrelin which was a adipokine that 
has modulatory effects on immune system. Two major forms of ghrelin are seen: 
i)Des-acylated ghrelin ii)Acylated ghrelin. This study includes 70 subjects grouped 
into 35 chronic periodontitis patients and 35 individuals without periodontitis. The 
results demonstrated that there was an increase of total and acylated ghrelin levels in 
chronic periodontitis patients compared with controls. 
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  Jentsch S et al., (2017)(22) reported about chemerin which was identified as 
an adipokine. Three chemerin receptors are known: i)chemokine-like receptor 1 ii)G 
protein receptor 1 iii)C-C chemokine receptor-like 2. Totally 60 subjects were taken 
and categorized into two main groups with chronic periodontitis patients and 
periodontally healthy subjects. They were again categorized into subjects with normal 
weight and overweight/obese subjects. The levels of acylated and total ghrelin and 
chemerin were assessed in saliva, GCF and serum. This study demonstrated that 
periodontitis patients had low ghrelin and high chemerin levels in the gingival 
crevicular fluid which might be associated with periodontitis and obesity. Therefore 
chemerin and ghrelin has been proposed as a biomarker for periodontitis. 
 Boyapati R et al., (2018)(23) conducted a study with fifty subjects categorized 
into obese chronic periodontitis patients and non obese chronic periodontitis patients. 
The effects of obesity and periodontal status on serum leptin and adiponectin levels of 
both groups were analyzed using ELISA assay. He reported that the plaque index and 
gingival index scores was higher in obese chronic periodontitis patients than non 
obese chronic periodontitis patients. Serum leptin levels were increased and serum 
adiponectin levels were decreased in obese chronic periodontitis patients compared to 
non obese chronic periodontitis patients. 
Biomarkers 
 Strimbu K et al., (2010)(24) reported that  biomarkers may be defined as a 
characteristic that is objectively measured and evaluated as an indicator of normal 
biological processes, pathogenic processes, or pharmacologic responses to a 
therapeutic intervention. 
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Saliva as a diagnostic fluid in periodontal diseases 
 Malamud D et al., (2006)(25) has suggested the possible use of oral fluids such 
as saliva for the assessment of periodontal diseases. Secretions from major salivary 
glands, which has large number of proteins and peptides were found to be responsible 
for maintaining the integrity of the oral cavity. Also, because of saliva’s importance in 
oral biofilm formation and host defense, saliva may have a significant role in the 
establishment and development of periodontal disease. 
  Kaufman E et al., (2000)(26) reviewed that saliva was a fluid easily collected 
and has periodontal disease markers which was locally and systemically derived. 
Therefore it can be used for patient speciﬁc diagnostic test for periodontitis. Host 
derived enzymes in saliva were promising indicators for periodontal disease. 
 Totan A et al., (2006)(27) reported a study in which totally 50 subjects were 
taken categorized into controls and patients with periodontal disease. It was found that 
elevated salivary ALP activity in periodontitis could be associated with alveolar bone 
destruction. Salivary ALP therefore can be used as a potential marker for monitoring 
periodontal disease. 
 Chiappin S et al., (2007)(28) reviewed that saliva makes it possible to monitor 
many biomarkers. It was because of its linkage with biochemical parameters which is 
seen in circulation in other forms. It was also a simple and non-invasive method for 
diagnosis. 
 Giannobile VW et al., (2009)(29) proposed that secreted saliva may have a 
important role in initiation and progression of periodontal disease due to its 
significance in biofilm formation and host defense. Saliva was a mirror of the body. 
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So biomarkers of saliva can be used to monitor health, onset of specific diseases, 
treatment response and outcomes. Saliva has components of host derived and 
microbial derived factors like protein degrading enzymes like elastase, lysozyme and 
proteoglycans. 
 Kim JJ et al., (2013)(30) proposed that collecting saliva employs noninvasive 
methods and since it was an abundant and easily accessible biofluid it was attractive 
for diagnostic purposes because of its highly enriched content of disease biomarkers 
that can be detected and assessed. Biomarkers for detection of diseases like sjogren’s 
syndrome, pancreatic, breast and oral cancer or periodontal diseases can be found in 
saliva.        
 Karam TA et al., (2015)(31) conducted a study on salivary resistin levels 
which were assessed using ELISA in 42 subjects grouped into controls, gingivitis and 
chronic periodontitis patients. Salivary resistin levels was increased in chronic 
periodontitis patients when compared with other groups. It shows that there was an 
association of periodontal conditions with serum resistin levels. 
Gingival Crevicular Fluid 
 Curtis MA et al., (1988)(32) studied the total protein concentration of gingival 
crevicular fluid in 32 healthy adolescents. He reported that GCF can be considered as 
an promising medium for the detection of markers of periodontal disease activity. It 
contains potential markers derived not only from host tissues and serum but it also has 
subgingival microbial plaque and thus an broad range of candidate molecules can be 
investigated. 
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 Armitage CG et al., (2004)(33) reviewed about the possible biomarkers in 
gingival crevicular fluid which plays an important role in the progression of 
periodontitis. These components were classified in 3 categories:1)Host derived 
enzymes and their inhibitors 2)Inflammatory mediators and host response modifiers 
3)Tissue breakdown products. Over 65 GCF components has been detected as 
possible markers for the progression of periodontitis. 
 Gupta G et al., (2012)(34) reported that GCF was an inflammatory exudate 
which seeps into gingival crevices or periodontal pockets around teeth with inflamed 
gingiva. It was composed of serum and locally generated materials like tissue 
breakdown products, inflammatory mediators and antibodies released against bacteria. 
Its composition was the result of the interaction between bacterial biofilm in the tooth 
surfaces and the cells of periodontal tissues. As GCF detects changes in the 
periodontal tissues that secrete it, an thorough investigation of its components identify 
potential diagnostic or prognostic markers playing a role in periodontitis. 
 Patel SP et al., (2013)(35) conducted a study on 96 subjects. The resistin levels 
in GCF from periodontitis or diabetes mellitus related periodontitis patients were 
elevated than that of healthy subjects. Gingival index was also found to be elevated in 
periodontitis or diabetes mellitus related periodontitis patients than that of healthy 
subjects. 
 Rahnama M et al., (2014)(36) reviewed that gingival crevicular fluid was seen 
as a window for painless analysis of periodontitis by detecting the presence of 
indicators and markers of connective tissue and bone destruction. Active phase of 
periodontal disease progression can be detected by the components of gingival fluid. 
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 Barros PS et al., (2016)(37) reported that GCF collection was painless and due 
to this fact it has been widely studied for finding potential diagnostic biomarkers of 
periodontal disease. GCF seems to be an attractive oral fluid because of its ease of 
collection and allowing for sampling of multiple sites in the oral cavity at the same 
time. 
 Dogan SB et al., (2016)(38) conducted a study on 60 subjects. Clinical 
parameters like probing depth, bleeding on probing, plaque index, gingival index 
levels were decreased and clinical attachment level was increased in the chronic 
periodontitis groups 6 weeks after SRP. In this study increased vaspin and decreased 
omentin-1 levels were seen in GCF by analyzing with ELISA in chronic periodontitis 
patients both with and without diabetes. SRP was beneficial for decreasing levels of 
both. Thus GCF vaspin and omentin-1 can be used as diagnostic and prognostic 
markers for diabetes, periodontitis and also to check their response to therapy. 
Adiponectin 
 Lihn AS et al., (2005)(39) reviewed about adiponectin which was a secreted 
protein of 247 amino acids mainly produced by adipocytes. Adiponectin gene was 
located on chromosome 3q27. Adiponectin has three domains: i)Globular domain 
near the C terminus ii)A signal sequence at the N terminus iii)A collagen-like domain. 
Adiponectinin circulation was seen in at least two forms as a hexamer: i)Low 
molecular weight (LMW) oligomer has two trimers ii)High molecular weight (HMW) 
oligomers has four to six trimers. High molecular weight oligomers form the major 
part of intracellular adiponectin whereas the abundant form of adiponectin in the 
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circulation was low molecular weight oligomers. Two receptors for adiponectin was 
identified i)ADIPOR1 ii)ADIPOR2. 
  Yamaguchi N et al., (2006)(40) observed that adiponectin acted as a potent 
inhibitor of A.actinomycetemcomitans induced osteoclast formation which was 
stimulated by Toll like receptor 4 ligand and receptor activator of NF-kB ligand. A 
luciferase assay showed that adiponectin was able to suppress the TLR4-mediated 
NF-kB activity in RAW264 cells. Adiponectin also inhibited TLR4-mediated 
expression of the gene for A.actinomycetemcomitans inducible nitric oxide synthase 
and production of nitric oxide in the cells. The observations in the study indicates that 
adiponectin was a potent negative regulator of the initiation and progression of 
periodontitis.   
 Furugen R et al., (2008)(41) reported about serum adiponectin levels in 158 
subjects with or without periodontitis. Adiponectin levels were analysed with ELISA 
assay. He observed decreased levels of adiponectin in subjects with periodontitis. 
Adiponectin levels were negatively associated with leukocyte counts which increases 
in periodontitis which shows that adiponectin was an anti-inflammatory mediator. 
There was a tendency of decreased adiponectin levels in periodontitis in this study. 
  Saito T et al., (2008)(42) conducted a study on 76 subjects categorized as 
periodontitis and controls. The serum level of adiponectin was analyzed with ELISA 
assay. It was found that there was an association of periodontitis with decreased level 
of adiponectin in serum. 
 Nagano Y et al., (2011)(43) conducted a study on 151 subjects categorized into 
periodontitis patients and controls. Serum high molecular weight adiponectin levels 
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was assessed with an ELISA kit. High molecular weight form of adiponectin has been 
reported to play a primary role in the physiological function of this adipocytokine. 
The ratio of high molecular weight adiponectin to total adiponectin was significantly 
decreased in subjects with periodontal pockets. These findings suggested that the ratio 
of high molecular weight adiponectin to total adiponectin can be a novel biomarker 
for evaluation of periodontal health. 
 Azawy VSA et al., (2015)(44) conducted a study on 55 subjects categorized 
into chronic periodontitis patients and controls. He reported that on analyzing with 
ELISA kit there is a significant decrease in serum adiponectin and increase of serum 
leptin level in chronic periodontitis patients compared to control group. The ratio of 
leptin/adiponectin was increased in periodontitis patient group when compared with 
the ratio in control group. This study indicates that serum levels of leptin and 
adiponectin plays an important role in pathogenesis of periodontitis and the relative 
leptin/adiponectin ratio is indicative of periodontitis. 
Resistin 
Furugen R et al., (2010)(5) reviewed about resistin which was a 12.5 kDa 
polypeptide hormone and a cysteine rich protein seen in inflammatory zone. Human 
resistin has 108 amino acids whereas rat and mouse resistin have 114 amino acids. It 
was a member of a family of tissue specific signaling molecules called resistin like 
molecules. Resistin belongs to the “found in inflammatory zones” family (FIZZ). 
Resistin was produced by white and brown adipose tissues but has also been seen in 
several other tissues like hypothalamus, pituitary, adrenal glands, pancreas, myocytes, 
spleen, gastrointestinal tract white blood cells and plasma. It opposes insulin action 
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and was inhibited by rosiglitazone and peroxisome proliferator activated receptor 
agonists. 
 Furugen R et al., (2011)(45) reported that A.actinomycetemcomitans produced 
leukotoxin induced extracellular release of human neutrophil derived resistin. There 
was also an increase in the prevalence and levels of A.actinomycetemcomitans in 
periodontal patients which contribute to their higher circulating levels of resistin.  
Also resistin was shown to mediate its proinflammatory effects via TLR-4 in culture 
supernatants of neutrophils. The expression level of TLR-4 was higher in all 
periodontal patients than in healthy individuals.  
 Devanoorkar A et al., (2012)(46) conducted a study on 40 patients categorized 
as healthy and chronic periodontitis. It was observed that periodontal parameters like 
plaque index, gingival index, sulcus bleeding index, probing depth were reduced after 
6-8 weeks with SRP. Serum resistin levels were assessed with ELISA assay. It was 
found that there was an increase in the serum resistin level in periodontitis group. 
Serum resistin level decreased after SRP in periodontitis patients. 
 Devanoorkar A et al., (2014)(47) reviewed that periodontal pathogens produce 
lipopolysaccharides which induce the resistin gene in macrophages through a cascade 
involving the production of proinflammatory mediators. It was observed that levels of 
resistin were increased in periodontitis and resistin plays an important role in inducing 
insulin resistance increasing the risk for type II diabetes. Obesity was another 
important risk factor for type II diabetes and has also been linked positively to 
periodontitis. Obesity, diabetes and chronic periodontitis are related to each other and 
obese subjects are at increased risk for diabetes as well as chronic periodontitis, 
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thereby showing a triangular relationship among the above three conditions and 
resistin may act as a connecting molecular link between these conditions. 
 Sabir DA et al., (2015)(48) reported  a study by evaluating salivary resistin 
levels using ELISA. The study included 75 subjects and they were grouped into 
healthy and chronic periodontitis patients with and without diabetes. Clinical 
periodontal parameters like plaque index, gingival index, bleeding on probing, 
probing pocket depth and clinical attachment level were worsened in chronic 
periodontitis with type 2 diabetes mellitus. Salivary resistin levels were elevated in 
chronic periodontitis with type 2 diabetes mellitus. Salivary Resistin could thus be 
used as a biomarker for periodontitis and type 2 diabetes mellitus. 
  Mittal M et al., (2015)(49) conducted a study on 100 subjects categorized into 
healthy, chronic periodontitis patients, rheumatoid arthritis patients and patients with 
both. The clinical parameters like plaque index, gingival index, probing depth were 
increased in chronic periodontitis patients and subjects with both chronic periodontitis 
and rheumatoid arthritis. GCF resistin levels when analysed with ELISA showed a 
decrease in healthy subjects whereas it was markedly increased in patients with 
chronic periodontitis and rheumatoid arthritis. Hence it can be concluded that GCF 
resistin can be considered as potential inflammatory marker for periodontitis and 
rheumatoid arthritis. 
 Rao RM et al., (2016)(50) conducted a study on 30 subjects grouped into obese 
healthy and obese chronic periodontitis patients. Clinical parameters like gingival 
index was higher and clinical attachment level was found to be lower in obese patients 
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with periodontitis. ELISA was used to analyse resistin levels in both serum and saliva. 
Resistin levels were markedly elevated in obese periodontitis group of patients. 
 Suresh S et al., (2016)(51) conducted a study on 90 subjects in which GCF 
resistin levels were analysed using ELISA. It was demonstrated that obese subjects 
with periodontitis have higher GCF resistin levels when compared to nonobese 
subjects with healthy periodontium.  
 Esfahrood ZR et al., (2018)(52) reported a study on salivary resistin levels in 
34 subjects grouped into healthy and chronic periodontitis. Resistin levels were 
assessed using ELISA. Higher resistin levels were seen in chronic periodontitis 
patients. Salivary resistin can thus be used to determine the inflammatory status in 
periodontitis. 
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 A randomized controlled clinical study was conducted to evaluate the GCF 
levels of adiponectin and resistin in periodontal health, disease and after treatment. 
The protocol was reviewed and approved by institutional ethical board. A informed 
consent was obtained from the patients and the study related procedures were 
explained. A total of 50 subjects were recruited from the outpatient Department of 
Periodontics, J.K.K Nattraja Dental College and Hospitals, Komorapalayam, 
Tamilnadu based on the following criteria. 
INCLUSION CRITERIA 
1. Patient age group of 20-50 years of both sexes. 
2. Minimum of 20 teeth to be present in every patient. 
3. Minimum of 2 sites with more than 5mm of pocket depth as assessed by 
williams periodontal probe. 
4. Minimum of 6 sites which shows bleeding on probing.  
5. Subjects who had not received any periodontal treatment in previous 6 
months. 
6. Systemically and periodontally healthy subjects with probing depth less than 3 
mm for the healthy group. 
EXCLUSION CRITERIA 
1. Patients suffering from known systemic diseases. 
2. Patients who are pregnant and lactating. 
3. Patients who are smokers and alcoholics. 
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4. Patients who received any chemotherapeutic mouth rinse or oral irrigation 
during past 6 months. 
5. Patients who received surgical or non surgical therapy in last 6 months. 
6. Patients with aggressive periodontitis. 
7. Patients who received any antibiotic therapy in the last 6 months. 
A randomized controlled clinical study was conducted in a total of 50 patients 
categorized into 25 patients who were periodontally and systemically healthy and 25 
patients with generalized chronic periodontitis. GCF samples were collected from the 
patients (Fig 3). Clinical parameters were measured before and after SRP. 
Biochemical analysis of adiponectin and resistin were assessed in the GCF samples. 
STUDY DESIGN 
Group I (healthy): Consists of 25 subjects with clinically healthy periodontium. 
Group II (chronic periodontitis): Consists of 25 subjects with clinical signs of 
gingival inflammation. 
        Probing depth (PD) ≥ 5mm  
Group III (after treatment group): Consists of 25 subjects of group II treated by 
scaling and root planing (SRP). 
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CLINICAL PARAMETERS 
        The following variables were measured at baseline and at 21 days of scaling 
and root planing. 
 Plaque index (PI) (Silness P and Loe H 1964) 
 Gingival index (GI) (Loe H and Silness P 1963) 
 Sulcus Bleeding Index (SBI) (Muhlemann HR and Son S  1971) 
 Probing Pocket Depth (PPD) 
 Clinical attachment level (CAL) 
1. Plaque index (Silness P and Loe H 1964) 
             The four gingival areas of the tooth surfaces examined are the disto-facial, 
facial, mesio-facial and lingual surfaces using explorer. 
Scoring was as follows:  
0 – No plaque. 
1 – A film of plaque adhering to the free gingival margin and adjacent area of the 
tooth. The plaque may be seen only by running a probe across the tooth surface. 
2 – Moderate accumulation of soft deposits within the gingival pocket, on the gingival 
margin and/or adjacent tooth surface, which can be seen by the naked eye.  
3 – Abundance of soft matter within the gingival pocket and/or on the gingival margin 
and adjacent tooth surface.  
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               The scores of the four areas of the tooth can be summed and divided by four 
to give the PI for the tooth. A score from  
                                                   0.1– 0.9 – Good 
                                                   1.0– 1.9 – Fair 
                                                   2.0– 3.0 – Poor 
2. Gingival index (Loe H and Silness P 1963) 
 The Gingival index was created to assess the severity of gingivitis based on its 
color, consistency and bleeding on probing. The tissues surrounding each tooth are 
divided into four gingival scoring units: Distal facial papillae, Facial margin, Mesial 
facial papillae, Entire lingual gingival margin. 
The criteria are 
0 – Normal gingiva 
1 – Mild inflammation – slight change in color and slight oedema but no bleeding on 
probing. 
2 – Moderate inflammation  – redness, oedema and bleeding on probing. 
3 – Severe inflammation – marked redness and oedema, ulceration with tendency to 
spontaneous bleeding. 
              The scores of the four areas of the tooth can be summed and divided by four 
to give the GI for the tooth.  
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A score from. 
                                               0.1– 1.0 – Mild inflammation 
                                               1.1– 2.0 – Moderate inflammation 
                                                2.1 – 3.0 – Severe inflammation 
3. Sulcus Bleeding Index (Muhlemann HR and Son S 1971) 
          An early sign of gingivitis is bleeding on probing. The criteria for scoring are 
as follows: 
 Score 0 – healthy looking papillary and marginal gingiva, no bleeding on probing; 
 Score 1 – healthy looking gingiva, bleeding on probing; 
 Score 2 – bleeding on probing, change in color, no edema; 
 Score 3 – bleeding on probing, change in color, slight edema; 
 Score 4 –bleeding on probing, change in color, obvious edema; 
 Score 5 –spontaneous bleeding, change in color, marked edema. 
 Four gingival units are scored systematically for each tooth: the labial and 
lingual marginal gingival (M units) and the mesial and distal papillary gingival (P 
units). Scores for these units are added and divided by four. Adding the scores of the 
undivided teeth and dividing them by the number of teeth can determine the sulcus 
bleeding index. 
 The least score is 0. The maximum score is 320. 
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4. Probing pocket depth (PPD) 
 The depth of the pocket was measured using william’s graduated periodontal 
probe. The probe was inserted parallel to the long axis of the tooth gently, until 
resistance was felt and the readings were recorded to the nearest millimeter from the 
gingival margin to the base of the pocket. Acrylic stents were used to standardize the 
path of insertion and angulations of the probe. 
5. Clinical attachment level (CAL) 
           The level of attachment is the distance between the base of the pocket and 
Cementoenamel Junction (CEJ) or a fixed reference point. The distance from the CEJ 
(if CEJ not detected, the coronal border of the stent was used) to the base of the 
pocket was measured. The readings were recorded to the nearest millimetre. 
Clinical evaluation of subjects 
 Subjects were selected for each group after a brief and precise case history 
recording that included patients chief complaint and clinical examination. Clinical 
examination was done using a sterile mouth mirror and a William’s periodontal probe. 
Site specific scoring was followed, where in, the site showing most severe 
inflammatory signs or greater amount of attachment loss was selected for GCF sample 
collection. PI and GI scores were recorded before to aid in site selection and the PD 
and CAL measurements were recorded after GCF collection to avoid contamination 
of the sample. 
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Procedure for gingival crevicular fluid collection 
 Subjects selected for sampling were made to sit comfortably in an upright 
position on the dental chair with proper illumination. The test site selected for 
sampling was air dried, isolated with cotton roll and supragingival plaque was 
removed without touching marginal gingiva. Sample of GCF were obtained by 
placing 1-5µL calibrated volumetric microcapillary pipettes which were obtained 
from sigma Aldrich chemicals company, Limited, USA (Fig 2). From each test site, a 
standardized volume of 2µL was collected using the calibration on micropipette and 
placing the tip of the pipette extracrevicularly for 30 seconds. GCF contaminated with 
saliva and blood were discarded. Samples of GCF were collected at the initial visit in 
group I, group II, group III subjects. Each gingival crevicular fluid sample was 
immediately placed into a sterile, labelled eppendorf tube and placed on ice then 
transported to the laboratory for processing.  
Non-surgical Periodontal therapy 
 Periodontal treatment (SRP) was performed for periodontitis patients at the 
same appointment after GCF collection. At baseline full mouth ultrasonic scaling was 
done. Under local anesthesia with 2% lignocaine solution (1:80,000), root planning 
was done using area-specific double-ended Gracey curettes (Hu-Friedy). After 21 
days, GCF was collected from the same site of the subjects in group III. Clinical 
parameters were repeated after 21 days. 
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Bio-Chemical evaluation of adiponectin and resistin using ELISA 
 The samples were then assayed for adiponectin and resistin levels by using 
Enzyme linked Immunosorbent Assay Kit for adipnectin (ITEH2593) and resistin 
(ITEH0269) from Immunotag™. 
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Determination of adiponectin level in GCF using ELISA 
Principle of the Assay 
 This kit was based on sandwich enzyme-linked immune-sorbent assay 
technology. Anti- ADP antibody was pre-coated onto 96-well plates. The biotin 
conjugated anti- ADP antibody was used as detection antibody. The standards, test 
samples and biotin conjugated detection antibody were added to the wells 
subsequently, and washed with wash buffer. HRP-Streptavidin was added and 
unbound conjugates were washed away with wash buffer. TMB substrates were used 
to visualize HRP enzymatic reaction. TMB was catalyzed by HRP to produce a blue 
color product that changed into yellow after adding acidic stop solution. The density 
of yellow is proportional to the ADP amount of sample captured in plate. Read the 
O.D. absorbance at 450nm in a microplate reader, and then the concentration of ADP 
can be calculated.  
Kit components  
1. ELISA microplate(Dismountable) 
2. Lyophilised standard 
3. Sample/Standard dilution buffer 
4. Biotin-labelled antibody(Concentrated) 
5. Antibody dilution buffer 
6. HRP-Streptavidin conjugate(SABC) 
7. TMB substrate 
8. Stop solution 
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9. Wash buffer 
10. Plate sealer 
Precautions 
1. To inspect the validity of experiment operation and the appropriateness of 
sample dilution proportion, pilot experiment using standards and a small 
number of samples is recommended.  
2. After opening and before using, keep plate dry.  
3. Before using the Kit, spin tubes and bring down all components to the bottom 
of tubes.  
4. Storage TMB reagents avoid light.  
5. Washing process is very important, not fully wash easily cause a false 
positive.  
6. Duplicate well assay is recommended for both standard and sample testing.  
7. Don’t let Micro plate dry at the assay, for dry plate will inactivate active 
components on plate.  
8. Don’t reuse tips and tubes to avoid cross contamination.  
9. Avoid using the reagents from different batches together.  
Material required but not supplied  
1. Microplate reader (wavelength: 450nm)  
2. 37°C incubator  
3. Automated plate washer 
4. Precision single and multi-channel pipette and disposable tips  
5. Clean tubes and Eppendorf tubes 
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6. Deionized or distilled water 
Manual washing 
 Discard the solution in the plate without touching the side walls. Clap the plate 
on absorbent filter papers or other absorbent material. Fill each well completely with 
350ul wash buffer and soak for 1 to 2 minutes, then aspirate contents from the plate, 
and clap the plate on absorbent filter papers or other absorbent material. Repeat this 
procedure two more times for a total of three washes.  
Automatic washing  
 Aspirate all wells, and then wash plate three times with 350ul wash buffer. 
After the final wash, invert plate, and clap the plate on absorbent filter papers or other 
absorbent material. It is recommended that the washer shall be set for soaking 1 
minute.  
Assay procedure 
1. Wash plate 2 times before adding standard, sample and control (zero) wells. 
2. Add 100μL standard or sample to each well and incubate for 90 minutes at 
37°C.  
3. Aspirate and wash plates 2 times. 
4. Add 100μL biotin-labeled antibody working solution to each well and 
incubate for 60 minutes at 37°C.  
5. Aspirate and wash plates 3 times.  
6. Add 100μL SABC working solution into each well and incubate for 30 
minutes at 37°C. 
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7. Aspirate and wash plates 5 times. 
8. Add 90μL TMB substrate. Incubate 15 -30 minutes at 37°C. 
9. Add 50μL stop solution. Read at 450nm immediately.  
10. Calculation. 
Determination of resistin level in GCF using ELISA 
Principle of the assay  
 This kit was based on sandwich enzyme-linked immune-sorbent assay 
technology. Anti- RETN antibody was pre-coated onto 96-well plates. The biotin 
conjugated anti-RETN antibody was used as detection antibody. The standards, test 
samples and biotin conjugated detection antibody were added to the wells 
subsequently, and wash with wash buffer. HRP-Streptavidin was added and unbound 
conjugates were washed away with wash buffer. TMB substrates were used to 
visualize HRP enzymatic reaction. TMB was catalyzed by HRP to produce a blue 
color product that changed into yellow after adding acidic stop solution. The density 
of yellow is proportional to the RETN amount of sample captured in plate. Read the 
O.D. absorbance at 450nm in a microplate reader, and then the concentration of 
RETN can be calculated. 
Kit components 
1. Micro ELISA plate (Dismountable) 
2. Lyophilised standard 
3. Sample/Standard dilution buffer 
4. Biotin-detection antibody(Concentrated) 
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5. Antibody dilution buffer 
6. HRP-Streptavidin conjugate(SABC) 
7. SABC dilution buffer 
8. TMB substrate 
9. Stop solution 
10. Wash buffer 
11. Plate sealer 
Precautions for use 
1.  To inspect the validity of experiment operation and the appropriateness of 
sample dilution proportion, pilot experiment using standards and a small 
number of samples is recommended.  
2.  After opening and before using, keep plate dry.  
3.  Before using the Kit, spin tubes and bring down all components to the bottom 
of tubes.  
4.  Storage TMB reagents avoid light.  
5.  Washing process is very important, not fully wash easily cause a false 
positive.  
6.  Duplicate well assay is recommended for both standard and sample testing. 
7.  Don’t let Micro plate dry at the assay, for dry plate will inactivate active 
components on plate.  
8.  Don’t reuse tips and tubes to avoid cross contamination.  
9.  Avoid using the reagents from different batches together.  
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Material required but not supplied  
1. Microplate reader (wavelength: 450nm)  
2. 37°C incubator  
3. Automated plate washer  
4. Precision single and multi-channel pipette and disposable tips  
5. Clean tubes and Eppendorf tubes 
6. Deionized or distilled water  
Manual washing  
 Discard the solution in the plate without touching the side walls. Clap the plate 
on absorbent filter papers or other absorbent material. Fill each well completely with 
350ul wash buffer and soak for 1 to 2 minutes, then aspirate contents from the plate, 
and clap the plate on absorbent filter papers or other absorbent material. Repeat this 
procedure two more times for a total of three washes. 
Automated washing  
 Aspirate all wells, then wash plate three times with 350ul wash buffer. After 
the final wash, invert plate, and clap the plate on absorbent filter papers or other 
absorbent material. It is recommended that the washer be set for a soaking time of 1 
minute.  
Assay procedure 
1. Wash plate 2 times before adding standard, sample and control (zero) wells. 
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2. Add 100μL standard or sample to each well for 90 minutes at 37°C.  
3. Add 100μL biotin-detection antibody working solution to each well for 60 
minutes at 37°C. Aspirate and wash 3 times. 
4. Add 100μL SABC working solution to each well. Incubate for 30 minutes at 
37°C. 
5. Aspirate and wash 5 times.  
6. Add 90μL TMB substrate. Incubate 15 -30 minutes at 37°C.  
7. Add 50μL stop solution. Read at 450nm immediately.  
8. Calculation of results. 
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APPENDIX - 1 
PROFORMA 
NAME:  O.P NUMBER: 
AGE:        DATE: 
SEX:        CASE NO: 
ADDRESS:       OCCUPATION: 
 
CHIEF COMPLAINT: 
 
 DENTAL HISTORY: 
 
MEDICAL HISTORY: 
 
PERSONAL HISTORY: 
 
TEST SITE : 
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CLINICAL PARAMETERS 
AT BASELINE 
PLAQUE  INDEX 
 
Score    
Interpretation 
 
GINGIVAL INDEX 
 
Score    
Interpretation 
 
 
 
B                                                 
P                   
 8 7 6 5 4 3 2 1 1 2 3 4 5 6 7 8 
B                                                 
L                   
 
 
B                                                 
P                   
 8 7 6 5 4 3 2 1 1 2 3 4 5 6 7 8 
B                                                 
L                   
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SULCUS  BLEEDING INDEX 
 
Score:  
Interpretation: 
PROBING POCKET DEPTH (mm) 
 
Score:  
CLINICAL ATTACHMENT LEVEL (mm) 
 
Score:  
 
 
B                                                 
P                   
 8 7 6 5 4 3 2 1 1 2 3 4 5 6 7 8 
B                                                 
L                   
 
 
                                                
                                                
8 7 6 5 4 3 2 1 1 2 3 4 5 6 7 8 
                                                
                                                
 
 
                                                
                                                
8 7 6 5 4 3 2 1 1 2 3 4 5 6 7 8 
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AT 3 WEEKS 
PLAQUE  INDEX 
 
Score:  
Interpretation: 
 
GINGIVAL INDEX 
 
Score:  
Interpretation: 
  
 
B                                                 
P                   
 8 7 6 5 4 3 2 1 1 2 3 4 5 6 7 8 
B                                                 
L                   
 
 
B                                                 
P                   
 8 7 6 5 4 3 2 1 1 2 3 4 5 6 7 8 
B                                                 
L                   
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SULCUS  BLEEDING INDEX 
 
Score:  
Interpretation: 
 
PROBING POCKET DEPTH (mm) 
 
Score:  
CLINICAL ATTACHMENT LEVEL (mm) 
 
Score:  
 
B                                                 
P                   
 8 7 6 5 4 3 2 1 1 2 3 4 5 6 7 8 
B                                                 
L                   
 
 
                                                
                                                
8 7 6 5 4 3 2 1 1 2 3 4 5 6 7 8 
                                                
                                                
 
 
                                                
                                                
8 7 6 5 4 3 2 1 1 2 3 4 5 6 7 8 
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J.K.K. NATTRAJA DENTAL COLLEGE, KOMARAPALAYAM 
DEPARTMENT OF PERIODONTICS 
INFORMED CONSENT OBTAINED FROM THE PATIENT 
PATIENT NAME 
 I have been explained about the nature and purpose of the study in which,  
I have been asked to participate. I understand that I am free to withdraw my consent 
and discontinue at any time without prejudice to me or effect on my treatment. 
 I have been given the opportunity to question about the material and study.  
I have also given the consent for photographs to be taken at the beginning, during and 
end of the study. I agree to participate in this study. 
 I hereby give the consent to be included in this study. 
 
Place:                                Signature of patient                                                                                    
Date:                                                                                            
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             APPENDIX – 2 
ARMAMENTARIUM (Fig 1) 
MATERIALS AND INSTRUMENTS USED FOR THE STUDY 
 Gloves 
 Mouth mask 
 Patient apron 
 Chair apron 
 Head cap 
 Sterile cotton rolls 
 Gauze 
 Saline 
 Kidney tray 
 Betadine 
 Lignocaine 
 Syringe 
 Mouth mirror 
 Straight probe 
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 Explorer 
 Williams periodontal probe 
 Hu-Friedy Gracey Curettes 
 Microcapillary pipettes 
 Eppendorf tubes  
 Phosphate buffered saline 
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ARMAMENTARIUM 
 
Fig 1: Armamentarium used for GCF collection and treatment 
 
 
Fig 2: Microcapillary pipettes and Eppendorf tubes used for GCF collection 
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Fig 3: Clinical cases 
  
Pre operative                                     GCF sample collection 
 
  
Scaling and root planning (SRP) Post operative (21 days) 
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Fig 4: Adiponectin ELISA Kit 
 
 
Fig 5: Resistin ELISA Kit 
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Fig 6: ELISA reader 
 
 
Fig 7: Pipetting GCF samples into aliquots for dilution 
 
 
  
 
RESULTS 
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 This clinico-biochemical study was done to explore the association between 
adiponectin and resistin levels in GCF in periodontal health and disease and to 
quantify the difference in adiponectin and resistin levels following periodontal 
therapy. 
 This randomized controlled clinical study consists of 50 subjects divided into 
3 groups i.e., healthy (Group I, 25 subjects), chronic periodontitis (Group II, 25 
subjects) and chronic periodontitis after treatment (Group III, 25 subjects) aged 
between 20-50 years from whom GCF were collected to estimate the levels of 
adiponectin and resistin using ELISA. 
 The results obtained were analysed statistically and comparisons of each group 
done using paired student t-distribution test. Further pearson correlation analysis was 
done to identify the correlation coefficient between the levels of adiponectin, resistin 
and clinical parameters. 
 The plaque index scores (PI) in group II was (2.86 ± 0.57) and reduced in 
group III to (1.76 ± 0.24). The comparison of PI scores between group II and group 
III shows a statistically significant difference with a P- value of < 0.001*. The results 
are shown in table 1 and graph 1. 
             The gingival index (GI) scores in group II was (2.62 ± 0.63) and reduced in 
group III to (1.73 ± 0.36). The Comparison of GI scores between group II and group 
III shows a statistically significant difference with a P-value of < 0.001*. The results 
are shown in table 1 and graph 1. 
 The sulcus bleeding index (SBI) scores in group II was (3.47 ± 0.45) and 
reduced in group III to (1.92 ± 0.52). The comparison of SBI scores between group II 
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and group III shows a statistically significant difference with a P-value of < 0.001*. 
The results are shown in table 1 and graph 1. 
             The probing depth (PD) scores in group II was (5.37 ± 0.43) and reduced in 
group III to (3.24 ± 0.54). The comparison of PD scores between group II and group 
III shows a statistically significant difference with a P-value of < 0.001*. The results 
are shown in table 1 and graph 2. 
  The clinical attachment level (CAL) scores in group II was (4.83 ± 0.32) and 
reduced in group III to (2.67 ± 0.41). The comparison of CAL scores between group 
II and group III shows a statistically significant difference with a P-value of < 0.001*. 
The results are shown in table 1 and graph 3. 
              The mean adiponectin levels in group I was (20.18 ± 0.26 ng/ml). The mean 
adiponectin levels in group II was (9.96 ± 0.27 ng/ml) and group III was (15.46 ± 0.32 
ng/ml). The results are shown in table 2 and graph 4. A statistically significant 
difference was observed between group II and group III with a P-value of <0.05.                 
              Further analysis was carried out to find out which pairs differ significantly at 
5% level of significance. A statistically significant difference was observed between 
group II and group III and between group I and group II with a P-value of <0.05. 
Statistically insignificant difference was obtained when the mean levels of 
adiponectin were compared between group I and group III with a P-value of >0.05. 
The results suggested that adiponectin levels decreased progressively in GCF from 
health to periodontitis and increased after periodontal therapy. 
               Pearson correlation analysis was done to test for any correlation between the 
adiponectin levels in GCF with the disease severity measures i.e., PI, GI, SBI, PD, 
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CAL in group II and group III.  A negative correlation was found between the clinical 
parameters and group II and group III. The results are shown in table 4 and graph 
6,7,8,9,10,11,12,13,14,15. 
 The mean resistin levels in group I was (7.19 ± 0.38 pg/ml). The mean levels 
of group II was (18.12 ± 0.43 pg/ml) and group III was (11.28 ± 0.39  pg/ml). The 
results are shown in table 3 and graph 5. A statistically significant difference was 
observed between group II and group III with a P-value of <0.05.                 
 Further analysis was carried out to find out which pairs differ significantly at 
5% level of significance. A statistically significant difference was observed between 
group II and group III and between group I and group II with a P-value of <0.05. A 
statistically insignificant difference was obtained when the mean levels of resistin 
were compared between group I and group III with a P-value of >0.05. The results 
suggested that resistin levels increased progressively in GCF from health to 
periodontitis and decreased after periodontal therapy. 
               Pearson correlation analysis was done to test for any correlation between the 
resistin levels in GCF with the disease severity measures i.e., PI, GI, SBI, PD, CAL in 
group II and group III. A positive correlation was found between the clinical 
parameters and group II and group III. The results are shown in table 4 and graph 6, 7, 
8, 9, 10, 11, 12, 13, 14, 15. 
                
 
  
 
TABLES 
 
Table 1
                Comparison of clinical parameters between group II and group III  
Indices Group II Group III p – value 
Plaque index 2.86 ± 0.57 1.76 ± 0.24 < 0.001*
Gingival index 2.62 ± 0.63 1.73 ± 0.36 < 0.001*
Sulcus bleeding index 3.47 ± 0.45 1.92 ± 0.52 < 0.001*
Probing depth(mm) 5.37 ± 0.43 3.24 ± 0.54 < 0.001*
Clinical attachment level(mm) 4.83 ± 0.32 2.67 ± 0.41 < 0.001*
*p – value < 0.001 denotes statistically significant at 1% level.
Table 2 
Comparison of Adiponectin levels between groups 
Adiponectin level (ng/ml) Mean±SD Comparison p -Value
Group I 20.18 ± 0.26 Group I Vs Group II < 0.05*
Group II 9.96  ± 0.27 Group II Vs Group III < 0.05*
Group III 15.46  ± 0.32 Group I Vs Group III > 0.05 
*  p – value < 0.05 denotes statistically significant at 5% level.
   p – value >0.05  denotes statistically insignificant at 5% level. 
Table 3 
Comparison of Resistin levels between groups 
Resistin level (pg/ml) Mean±SD Comparison p -Value
Group I 7.19  ± 0.38 Group I Vs Group II < 0.05*
Group II 18.12  ± 0.43 Group II Vs Group III < 0.05*
Group III 11.28  ± 0.39 Group I Vs Group III >0.05 
*  p – value < 0.05 denotes statistically significant at 5% level.
   p – value >0.05  denotes statistically insignificant at 5% level.
  
Table 4 
Correlation of clinical parameters with Adiponectin and Resistin levels 
 in each group 
Correlation coefficient of group II and group III 
Clinical parameters 
Adiponectin Resistin 
Group II Group III Group II Group III 
Plaque index -0.041 -0.037 0.074 0.053
Gingival index -0.049 -0.040 0.077 0.058
Sulcus bleeding index -0.054 -0.038 0.089 0.066
Probing depth -0.125 -0.107 0.152 0.128
Clinical attachment level -0.102 -0.093 0.145 0.120
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Graph 1 
 
Comparison of plaque index, gingival index and sulcus bleeding index between 
group II and group III 
Graph 2 
 
Comparison of probing depth between group II and group III 
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Graph 3 
 
Comparison of clinical attachment level between group II and group III 
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Graph 4 
 
 
Comparison of Adiponectin levels between groups 
 
Graph 5 
 
 
Comparison of Resistin levels  between groups 
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Graph 6 
 
 
 
Graph 7 
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Graph 8 
 
 
Graph 9 
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Graph 10 
 
 
Graph 11 
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               Periodontitis is a chronic inflammatory state caused by the interactions 
between pathogenic bacteria and host defense system. Bacterial byproducts such as 
lipopolysaccharides, antigen and virulence factors enters the gingival tissue to initiate 
the inflammatory reaction. As a result of this interaction, inflammatory mediators 
such as cytokines, chemokines, adipokines, arachidonic acid metabolites are released, 
which plays important role in disease progression and tissue destruction.                          
 Adipokines are group of biologically active molecules produced by the 
adipose tissue.  Adipokines such as adiponectin and resistin play an important role in 
periodontal inflammation. The present study was undertaken to evaluate the GCF 
levels of adiponectin and resistin in periodontal health, disease and after the treatment.  
                  In the present study the mean levels of adiponectin in GCF were found to 
decrease progressively from health 20.18 ± 0.26 ng/ml to periodontititis 9.96 ± 0.27 
ng/ml. The mean levels of adiponectin in chronic periodontitis increased from 9.96 ± 
0.27 ng/ml to 15.46 ± 0.32 ng/ml after treatment which is statistically significant.  
                 The results in our study was in accordance with Furugen et al(41) who found 
that there was decreased levels of adiponectin in subjects with periodontitis. 
Adiponectin levels were negatively associated with leukocyte counts which shows 
that adiponectin was an anti-inflammatory mediator.  
                 According to Tilg et al(18) expression of adiponectin was controlled by 
other pro-inflammatory mediators like IL-6 which inhibits adiponectin transcription 
and translation in adipocytes. Adiponectin induces the production of anti-
inflammatory cytokines like IL-10 and IL-1 receptor antagonist by human monocytes, 
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macrophages and dendritic cells and inhibits the release of interferon-γ by LPS 
stimulated human macrophages. Through its receptor ADIPOR1 globular adiponectin 
inhibits TLR-induced NF-κB activation which shows that adiponectin negatively 
regulates macrophage responses to TLR ligands which is of importance in innate 
immune responses. 
 The findings of our study were in line with that of Ling et al (53) who found that 
there was a significant decrease in serum adiponectin in chronic periodontitis 
compared to that of healthy controls. The increase in the levels of adiponectin after 
scaling and root planing could be due to the decrease of pro inflammatory cytokines 
like IL-6 and TNF- and elevation of inducible factors like IL-10 and IL-1RA which 
favors the anti–inflammatory role for adiponectin. 
 The correlation of adiponectin levels with the five clinical parameters of 
periodontal status were investigated. The adiponectin levels were negatively 
correlated with PI, GI, SBI, PD, CAL score in group III (-0.037, -0.040, -0.038,-0.107 
and -0.093 respectively). This indicates that the adiponectin levels were negatively 
associated with the degree of periodontal tissue destruction.  This was in accordance 
with the study conducted by Ling et al.(53) 
  In the present study the mean levels of resistin in GCF were found to 
increase progressively from health 7.19 ± 0.38 pg/ml to periodontitis 18.12 ± 0.43 
pg/ml. The mean levels of resistin in chronic periodontitis decreased from 18.12 ± 
0.43 pg/ml to 11.28 ± 0.39 pg/ml after treatment which is statistically significant.  
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 The increase in resistin levels observed in our study was in accordance with 
Saito et al(42) who found an increased level of serum resistin in association with 
periodontitis. It may be due to local involvement of monocytes and macrophages in 
periodontal inflammation. The increase in circulating resistin levels induced by 
periodontal disease might be derived from both periodontal and adipose tissues.  
 It was also in accordance with the study done by Karam et al(31) who reported 
an increase in serum resistin and salivary resistin with conversion from periodontal 
health state to periodontal disease state. Periodontopathic bacteria produces LPS 
and/or leukotoxin which increases the circulating resistin concentration. Inflammatory 
cells like monocytes and macrophages seen in the periodontal tissue appear to be the 
chief source of resistin. LPS produced by P.gingivalis can induce resistin release from 
neutrophils. There was an association of periodontal conditions with serum resistin 
levels since its levels were dramatically increased by LPS stimulation in humans.  
 Our results with resistin was in accordance with Furugen et al(41) who observed 
an increase in the serum resistin levels in subjects with periodontitis when compared 
with controls. Resistin expression increases along with the maturation of monocytes 
into macrophages. LPS from periodontal pathogenic bacteria influences adipose 
tissues and macrophages through inflammatory cytokines which causes an increase in 
the resistin level. 
 The findings of our study were in line with that of Suresh et al(54) who found 
that there was a significant decrease in GCF resistin levels in chronic periodontitis 
after treatment. The decrease in the levels of resistin after SRP could be due to the 
reduced expression of resistin by polymorphonuclear leukocytes and macrophages in 
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inflammatory conditions. This reduces the periodontal inflammation and thereby 
reduces the pro inflammatory cytokines like IL-12 and TNF-α leading to decrease in 
GCF resistin levels. 
 The correlation of resistin levels with the five clinical parameters of 
periodontal status were investigated. The resistin levels were positively correlated 
with PI, GI, SBI, PD, CAL score in group III (0.053, 0.058, 0.066, 0.128 and 0.120  
respectively). This indicates a positive correlation with the degree of periodontal 
tissue destruction. This was in accordance with the study conducted by Patel et al.(35)    
           Based on the results obtained from our study we can conclude that non surgical 
periodontal therapy (SRP) resulted in statistically significant increase in adiponectin 
and decrease in resistin in GCF and the clinical parameters of periodontal status also 
improved significantly. 
 Since our data shows that all the GCF samples tested positive to adiponectin 
and resistin, it can be considered as a biomarker of periodontal disease progression. 
However controlled longitudinal, prospective studies involving larger population and 
more solid phase assays are needed to verify this possibility. 
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           The invivo study was conducted to evaluate the GCF levels of Adiponectin and 
Resistin in chronic periodontitis patients before and after treatment. 
            The invivo study was designed as a Single Blind Randomized controlled 
clinical trial for a period of 3 weeks. The study population comprised of 50 subjects, 
and they were divided into three groups, 25 subjects in Group I (Healthy), Group II 
(Chronic periodontitis) and Group III (After treatment). Scaling and root planing was 
done in Group II and recalled after 3 weeks (Group III). 
         Clinical parameters such as Plaque Index, Gingival Index, Sulcus Bleeding 
Index, Probing depth and Clinical Attachment Level were evaluated. Biochemical 
evaluation of Gingival crevicular fluid Adiponectin and Resistin levels were done. 
Conclusion  
 Decreased levels of adiponectin and increased levels of resistin were detected 
in the gingival crevicular fluid of patients with chronic periodontitis.  
 Treatment of periodontal disease by scaling and root planing led to a 
proportional increase in adiponectin and decrease in resistin levels in GCF. 
 Further, as the concentration of adiponectin correlated negatively with the 
clinical parameters and the concentration of resistin correlated positively with 
the clinical parameters, it can be postulated that adiponectin and resistin were 
actively involved in playing a role in periodontal disease and thus could be 
considered as markers for periodontitis. 
 In summary, evaluation of adiponectin and resistin in GCF of chronic 
periodontitis patients could be used as a biomarker for prediction of active stage of the 
disease and periodontal destruction.  
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